
Panelists challenge the belief that testosterone fuels prostate cancer, explain PSA on therapy and TRAVERSE BPH data, and weigh Schedule III status.
Washington-While leaders of both political parties say they want to provideMedicare patients with meaningful coverage for prescription drug expenses,major philosophical differences threaten to make that objective extremelydifficult to achieve.





